Phase 2 Readout
ALXO: Phase 2 Readout: evorpacept
September 30, 2026 · evorpacept. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- September 30, 2026
- Company
- ALX ONCOLOGY HOLDINGS INC (ALXO)
- Drug
- evorpacept
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: evorpacept
- Drug
- evorpacept
- Indication
- HER2-positive metastatic breast cancer